HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mifepristone in primary care: no impediments against its use in management of missed miscarriage].

Abstract
In the Netherlands, medical treatment to women with a non-vital pregnancy is provided in secondary care. In a Dutch pilot study, it has been shown that treatment of a missed miscarriage with misoprostol in primary care is an acceptable alternative. However, there are clear indications that medical treatment in women with a non-vital pregnancy is greatly improved when mifepristone is prescribed in addition to misoprostol. The authors state that this treatment is also justified in primary care.
AuthorsPeter Leusink, Gunilla Kleiverda
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 165 (02 18 2021) ISSN: 1876-8784 [Electronic] Netherlands
Vernacular TitlePrescriptie van mifepriston in de eerste lijn?
PMID33651509 (Publication Type: Journal Article)
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Misoprostol
  • Mifepristone
Topics
  • Abortifacient Agents, Nonsteroidal (therapeutic use)
  • Abortion, Legal
  • Abortion, Missed (drug therapy)
  • Adult
  • Drug Therapy, Combination
  • Female
  • Humans
  • Mifepristone (therapeutic use)
  • Misoprostol (therapeutic use)
  • Netherlands
  • Pilot Projects
  • Pregnancy
  • Primary Health Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: